Akari TherapeuticsAKTX
13F holders, Q2 2024 (June 30)10holders +2
4new positions
2sold out
1famous investor
$2.71avg. 13F price*
At the end of Q2 2024, 10 institutions reported holding Akari Therapeutics PLC (AKTX) in their 13F filings, up 2 from Q1 2024. 4 opened new positions and 2 sold out. The largest holders were Omnia Family Wealth, LLC ($237K), Cerity Partners LLC ($64K) and Cresset Asset Management, LLC ($50K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Akari Therapeutics PLC
- CUSIP
- 00972G207
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $141K |
| Exits | 2 | $91K |
All 13F filers, Q1 2024 → Q2 2024: 53,987 shares bought and 48,541 shares sold, net +5,446 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Omnia Family Wealth, LLC | 0.10% | No change | 87,628 | $237K |
| Cerity Partners LLC | 0.00% | No change | 23,643 | $64K |
| Cresset Asset Management, LLC | 0.00% | New | 18,408 | $50K |
| Susquehanna International Group, LLP | 0.00% | New | 17,226 | $48K |
| Renaissance Technologies | 0.00% | Add +15.6% | 17,069 | $46K |
| UBS Group AG | 0.00% | New | 15,953 | $43K |
| Bank of America Corp. | 0.00% | No change | 150 | $405 |
| Osaic Holdings, Inc. | 0.00% | New | 100 | $270 |
| Cornerstone Planning Group LLC | 0.00% | No change | 5 | $18 |
| Morgan Stanley | 0.00% | No change | 6 | $16 |
"% of holder's portfolio" is AKTX's weight in each manager's 13F, not the share of Akari Therapeutics PLC the manager owns.